Management of relapsed Hodgkin's disease patients with high-dose chemotherapy and marrow stem-cell transplantation (Q74170626)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942051%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

editorial

0 references

title

Management of relapsed Hodgkin's disease patients with high-dose chemotherapy and marrow stem-cell transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942051%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

stem cell transplantation

1 reference

J O Armitage

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942051%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 June 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942051%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942051%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942051%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942051%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

645-646

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942051%20AND%20SRC:MED&resulttype=core&format=json

High-dose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's disease

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008302104009

7 January 2021

High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: long-term follow-up in 128 patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008302104009

7 January 2021

Autotransplantation for relapsed or refractory Hodgkin's disease: long-term follow-up and analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008302104009

7 January 2021

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008302104009

7 January 2021

Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008302104009

7 January 2021

Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure: a case-control study. Société Francaise de Greffe de Moelle.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008302104009

7 January 2021

Prolonged Disease-Free Survival in Hodgkin's Disease with MOPP Reinduction After First Relapse

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008302104009

7 January 2021

Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008302104009

7 January 2021

Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008302104009

7 January 2021

High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008302104009

7 January 2021

Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008302104009

7 January 2021

High-dose BEAM chemotherapy with autologous peripheral blood progenitor-cell transplantation for unselected patients with primary refractory or relapsed Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008302104009

7 January 2021

Identifiers

DOI

10.1023/A:1008302104009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942051%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference